| Literature DB >> 29360866 |
Bo Cui1, Chunxin Wang1, Xiang Zhao1, Junwei Yao1, Zhanghua Zeng1, Yan Wang1, Changjiao Sun1, Guoqiang Liu1, Haixin Cui1.
Abstract
Poorly water-soluble and photosensitive pesticide compounds are difficult to formulate as solvent-free nanoformulations with high efficacy. A avermectin solid nanodispersion with a mean particle size of 188 nm was developed by microprecipitation and lyophilisation techniques. The suspensibility and wetting time of the solid nanodispersion in water were 99.8% and 13 s, respectively, superior to those of conventional water dispersible granules and wettable powders. The anti-photolysis performance of the nanoformulation was twice that of the technical material, and the biological activity against diamondback moths was more than 1.5 times that of the conventional solid formulations while taking LC 50 as the evaluation index. Moreover, the formulation composition substantially decreased the surfactant content and avoided organic solvents. Microprecipitation combined with lyophilisation is an easy and promising method to construct solid nanoformulations for pesticides with poor water solubility and environmental sensitivity. The application of the highly effective solid nanodispersion in crop production will have a great potential in reducing chemical residues and environmental pollution.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29360866 PMCID: PMC5779682 DOI: 10.1371/journal.pone.0191742
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Effect of a single surfactant on the particle size and dispersibility of the avermectin aqueous dispersions.
| surfactant | mean size (nm) ± S.D. | PDI |
|---|---|---|
| SDS | 588 ± 43 de | 0.283 ± 0.224 a |
| SDBS | 480 ± 29 e | 0.239 ± 0.207 a |
| Polycarboxylate | 426 ± 36 e | 0.264 ± 0.194 a |
| MRES | 265 ± 11 e | 0.254 ± 0.026 a |
| SLES | 2317 ± 186 b | 0.584 ± 0.391 a |
| Tween 80 | 392 ± 5 e | 0.351 ± 0.040 a |
| Span 80 | 939 ± 74 d | 0.694 ± 0.531 a |
| PVP K30 | 4820 ± 568 a | 0.514 ± 0.243 a |
| HPMC | 1592 ± 272 c | 0.663 ± 0.430 a |
aSDS: 1-dodecanesulfonic acid sodium salt; SDBS: sodium dodecylbenzenesulfonate; MRES: maleic rosin-polyoxypropylene-polyoxyethylene ether sulfonate; SLES: sodium lauryl ether sulfate; Tween 80: polyoxyethylene sorbitan monooleate; Span 80: sorbitan monooleate; PVP K30: polyvinylpyrrolidone K30; HPMC: hydroxypropyl methylcellulose.
bPDI: polydispersity index.
cS.D.: standard deviation of three measurements.
Different letters indicate significant differences according to Duncan’s multiple range test at P < 0.05.
Effect of composite surfactants on the particle size and dispersibility of the avermectin aqueous dispersions.
| surfactant | mean size (nm) ± S.D. | PDI |
|---|---|---|
| MRES + SDS | 222 ± 4 b | 0.253 ± 0.018 b |
| MRES + SDBS | 240 ± 4 b | 0.328 ± 0.026 a |
| MRES + Polycarboxylate | 46 ± 1 c | 0.350 ± 0.046 a |
| MRES + SLES | 241 ± 1 b | 0.251 ± 0.014 b |
| MRES + Tween 80 | 226 ± 4 b | 0.218 ± 0.006 b |
| MRES + Span 80 | 212 ± 3 b | 0.202 ± 0.027 b |
| MRES + PVP K30 | 226 ± 4 b | 0.218 ± 0.021 b |
| MRES + HPMC | 431 ± 52 a | 0.059 ± 0.043 c |
aSDS: 1-dodecanesulfonic acid sodium salt; SDBS: sodium dodecylbenzenesulfonate; MRES: maleic rosin-polyoxypropylene-polyoxyethylene ether sulfonate; SLES: sodium lauryl ether sulfate; Tween 80: polyoxyethylene sorbitan monooleate; Span 80: sorbitan monooleate; PVP K30: polyvinylpyrrolidone K30; HPMC: hydroxypropyl methylcellulose.
bPDI: polydispersity index.
cS.D.: standard deviation of three measurements.
Different letters indicate significant differences according to Duncan’s multiple range test at P < 0.05.
Fig 1Particle size and dispersibility of the aqueous dispersions containing 4.0% (w/w) avermectin with different surfactant contents.
Different letters indicate significant differences according to Duncan’s multiple range test at P < 0.05.
Fig 2The morphology and particle size of the avermectin TC and nanoparticles.
(a) SEM image of TC with magnification of 8000; (b) TEM image of the nanoparticles with magnification of 40000; (c) Size of the nanoparticles measured by DLS. Size (d. nm): diameter of the nanoparticles.
Fig 3XRD patterns of the avermectin solid nanodispersion and pure components in the formulation.
Fig 4Stability of the avermectin solid nanodispersion at 25°C.
Different letters indicate significant differences according to Duncan’s multiple range test at P < 0.05.
Fig 5Photolysis of avermectin in the solid nanodispersion and technical material.
Bioassay results of four avermectin formulations.
| Formulation | Toxicity regression equation | Correlation coefficient | LC 50 | 95% confidence limit of LC 50 | LC 90b (μg/mL) | 95% confidence limit of LC 90 |
|---|---|---|---|---|---|---|
| Cuiwei WDG | Y = 2.2448+1.3173x | 0.9872 | 43.71 | 32.0~51.6 | 162.74 | 92.8–285.4 |
| Kaiwei WDG | Y = 1.9092+2.5132x | 0.9836 | 20.07 | 13.3~30.2 | 94.14 | 58.0–152.7 |
| Yipaohong WP | Y = 1.0118+2.6934x | 0.9992 | 184.43 | 159.2~213.6 | 3347.63 | 2333.5–4802.6 |
| Solid Nanodispersion | Y = 1.6857+3.1245x | 0.9664 | 12.96 | 7.9~21.3 | 74.61 | 35.6–156.4 |
aLC 50: median lethal concentration.
bLC 90: 90% lethal concentration.
cWDG: water dispersible granule.
dWP: wettable powder.